XML 37 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Research and Development
9 Months Ended
May 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Research and Development
Research and Development

We share the cost of certain product and process development activities with development partners. Our R&D expenses were reduced by reimbursements under these arrangements of $53 million and $167 million for the third quarter and first nine months of 2018, respectively, and $47 million and $162 million for the third quarter and first nine months of 2017, respectively.